Stephen J. Chanock, M.D., Chief of DCEG’s Laboratory of Translational Genomics and Director of the NCI Cancer Genomics Research Laboratory, was appointed Acting Co-Director of NCI’s Center for Cancer Genomics (CCG). He shares the position with Louis M. Staudt, M.D., Ph.D., of the Center for Cancer Research while NCI seeks a permanent director for CCG.
NCI established CCG with the mission of developing and applying genome science to better diagnose and treat cancer patients. CCG serves as the centerpiece for executing and coordinating NCI’s extensive and expanding activities in cancer genomics research, which include both genetic and epigenetic studies. During its first year, the center was headed by geneticist Dr. Barbara Wold who was on leave from the California Institute of Technology.